Non-pharmacological treatment of low back pain in primary care
original abstract †Abstracts here may not perfectly match originals, for a variety of technical and practical reasons. Some abstacts are truncated for my purposes here, if they are particularly long-winded and unhelpful. I occasionally add clarifying notes. And I make some minor corrections.
Key learning points:
* Low back pain (LBP) is the leading cause of disability worldwide and is associated with a significant personal, social and economic burden. * The use of often harmful and ineffective treatments (eg, opioids and surgery) represents a major challenge to the safe and appropriate management of non-specific LBP. * Greater emphasis is now placed on non-pharmacological treatments. * Self-care advice and reassurance should form the mainstay of non-pharmacological treatment for non-specific LBP, but there is a lack of guidance on how best to deliver reassurance in a way that is acceptable to people with LBP. * LBP is an unsolved problem and we currently lack truly effective treatments. Effects are often small and short lived and many treatments do not work at all. * Honesty about the current lack of a genuine cure for LBP may encourage a greater self-care approach to LBP, and clinicians should be careful not to overexaggerate the benefits of any one treatment.
This page is part of the PainScience BIBLIOGRAPHY, which contains plain language summaries of thousands of scientific papers & others sources. It’s like a highly specialized blog. A few highlights:
- Topical glyceryl trinitrate (GTN) and eccentric exercises in the treatment of mid-portion achilles tendinopathy (the NEAT trial): a randomised double-blind placebo-controlled trial. Kirwan 2024 Br J Sports Med.
- Placebo analgesia in physical and psychological interventions: Systematic review and meta-analysis of three-armed trials. Hohenschurz-Schmidt 2024 Eur J Pain.
- Recovery trajectories in common musculoskeletal complaints by diagnosis contra prognostic phenotypes. Aasdahl 2021 BMC Musculoskelet Disord.
- Cannabidiol (CBD) products for pain: ineffective, expensive, and with potential harms. Moore 2023 J Pain.
- Moderators of the effect of therapeutic exercise for knee and hip osteoarthritis: a systematic review and individual participant data meta-analysis. Holden 2023 The Lancet Rheumatology.